ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
Possibilities of modern antiplatelet and antithrombotic therapy at percutaneous coronary interventions in patients with coronary artery disease are surveyed. Data of multicenter randomized clinical trials and meta-analyses are discussed. Possibilities of various drugs at percutaneous coronary interv...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-01-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/1119 |
_version_ | 1826949686963994624 |
---|---|
author | V. A. Sulimov |
author_facet | V. A. Sulimov |
author_sort | V. A. Sulimov |
collection | DOAJ |
description | Possibilities of modern antiplatelet and antithrombotic therapy at percutaneous coronary interventions in patients with coronary artery disease are surveyed. Data of multicenter randomized clinical trials and meta-analyses are discussed. Possibilities of various drugs at percutaneous coronary interventions are reported from position of the international clinical guidelines. |
first_indexed | 2024-03-08T14:02:45Z |
format | Article |
id | doaj.art-1c8d9af3fb5746fc9ee672364bc5e353 |
institution | Directory Open Access Journal |
issn | 1819-6446 2225-3653 |
language | English |
last_indexed | 2025-02-17T22:18:33Z |
publishDate | 2016-01-01 |
publisher | Столичная издательская компания |
record_format | Article |
series | Рациональная фармакотерапия в кардиологии |
spelling | doaj.art-1c8d9af3fb5746fc9ee672364bc5e3532024-12-04T11:48:10ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-01439110010.20996/1819-6446-2008-4-3-91-1001118ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONSV. A. Sulimov0Moscow Medical Academy named after I.M. SetchenovPossibilities of modern antiplatelet and antithrombotic therapy at percutaneous coronary interventions in patients with coronary artery disease are surveyed. Data of multicenter randomized clinical trials and meta-analyses are discussed. Possibilities of various drugs at percutaneous coronary interventions are reported from position of the international clinical guidelines.https://www.rpcardio.online/jour/article/view/1119percutaneous coronary interventionantithrombotic therapy |
spellingShingle | V. A. Sulimov ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS Рациональная фармакотерапия в кардиологии percutaneous coronary intervention antithrombotic therapy |
title | ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS |
title_full | ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS |
title_fullStr | ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS |
title_full_unstemmed | ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS |
title_short | ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS |
title_sort | antithrombotic therapy at percutaneous coronary interventions |
topic | percutaneous coronary intervention antithrombotic therapy |
url | https://www.rpcardio.online/jour/article/view/1119 |
work_keys_str_mv | AT vasulimov antithrombotictherapyatpercutaneouscoronaryinterventions |